XML 153 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Current Assets:      
Cash and cash equivalents $ 74,000,000 $ 230,000,000  
Accounts receivable, less allowance for credit losses 889,000,000 690,000,000  
Allowance for credit losses 38,000,000 44,000,000  
Accrued unbilled revenues, allowance for credit loss 4,000,000 6,000,000  
Prepaid expenses and other current assets 171,000,000 132,000,000  
Other Assets:      
Total Non-Current Regulatory Assets $ 2,193,000,000 $ 2,321,000,000  
Shareholders’ Equity:      
Cumulative preferred stock, par value (in dollars per share) $ 0.01 $ 0.01 $ 0.01
Cumulative preferred stock, authorized (in shares) 20,000,000 20,000,000 20,000,000
Cumulative preferred stock, outstanding (in shares) 800,000 800,000 2,402,400
Cumulative preferred stock, aggregate liquidation preference $ 800 $ 800  
Common stock, par value (in dollars per share) $ 0.01 $ 0.01 $ 0.01
Common stock, authorized (in shares) 1,000,000,000 1,000,000,000 1,000,000,000
Common stock, outstanding (in shares) 629,535,631 628,923,534  
Variable Interest Entity, Primary Beneficiary      
Current Assets:      
Cash and cash equivalents $ 75,000,000 $ 92,000,000  
Accounts receivable, less allowance for credit losses 22,000,000 29,000,000  
Prepaid expenses and other current assets 13,000,000 19,000,000  
Other Assets:      
Total Non-Current Regulatory Assets $ 229,000,000 $ 420,000,000